SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000926617-18-000012
Filing Date
2018-03-13
Accepted
2018-03-13 16:35:11
Documents
67
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vrml-20171231x10k.htm 10-K 2034652
2 EX-10.21 vrml-20171231xex10_21.htm EX-10.21 36407
3 EX-21.0 vrml-20171231xex21_0.htm EX-21.0 7512
4 EX-23.1 vrml-20171231xex23_1.htm EX-23.1 6358
5 EX-31.1 vrml-20171231xex31_1.htm EX-31.1 20523
6 EX-31.2 vrml-20171231xex31_2.htm EX-31.2 20779
7 EX-32.0 vrml-20171231xex32_0.htm EX-32.0 12401
  Complete submission text file 0000926617-18-000012.txt   6957162

Data Files

Seq Description Document Type Size
8 EX-101.INS vrml-20171231.xml EX-101.INS 1402676
9 EX-101.SCH vrml-20171231.xsd EX-101.SCH 42199
10 EX-101.CAL vrml-20171231_cal.xml EX-101.CAL 50389
11 EX-101.DEF vrml-20171231_def.xml EX-101.DEF 150070
12 EX-101.LAB vrml-20171231_lab.xml EX-101.LAB 388114
13 EX-101.PRE vrml-20171231_pre.xml EX-101.PRE 335943
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
VERMILLION, INC. (Filer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34810 | Film No.: 18686921
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1